SCHEMBL16698152

SCHEMBL16698152

COc1ccc(C=O)cc1C#C[Si](C)(C)C

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 6/20 0.59
TSHR P16473 1/20 0.59
DYRK1A Q13627 7/20 0.56
CLK1 P49759 1/20 0.56
CLK2 P49760 1/20 0.56
CLK3 P49761 1/20 0.56
MELK Q14680 1/20 0.56
FDPS P14324 1/20 0.51
AOX1 Q06278 1/20 0.50
MAPT P10636 3/20 0.48
TTR P02766 1/20 0.48
TRIM24 O15164 1/20 0.46
HPGD P15428 1/20 0.46
ALDH5A1 P51649 1/20 0.46
ABAT P80404 1/20 0.46
TDP1 Q9NUW8 1/20 0.46
TRIM33 Q9UPN9 1/20 0.46
KDM4E B2RXH2 1/20 0.45
SMN1; SMN2 Q16637 2/20 0.43
LMNA P02545 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28415836 0.88 ALDH1A1 (0.54) ALDH1A1TSHRDYRK1ACLK1CLK2
SCHEMBL31098032 0.88 ALDH1A1 (0.54) ALDH1A1TSHRDYRK1ACLK1CLK2
SCHEMBL19923183 0.84 FDPS (0.46) ALDH1A1TSHRDYRK1ACLK1CLK2
SCHEMBL14387323 0.80 TUBB1 (0.55) DYRK1ACLK1CLK2CLK3MELK
SCHEMBL25187898 0.79 ALDH1A1 (0.44) ALDH1A1TSHRDYRK1ACLK1CLK2
SCHEMBL16709385 0.79 ALDH1A1 (0.38) ALDH1A1TSHRDYRK1ACLK1CLK2
SCHEMBL28416781 0.78 ALDH1A1 (0.37) ALDH1A1TSHRDYRK1ACLK1CLK2
SCHEMBL29198723 0.78 ALDH1A1 (0.52) ALDH1A1TSHRDYRK1ACLK1CLK2
SCHEMBL8887830 0.77 ALDH1A1 (0.50) ALDH1A1TSHRFDPSAOX1MAPT
SCHEMBL8891544 0.77 TTR (0.57) ALDH1A1TSHRFDPSAOX1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20150133467-A1 SCREENING METHOD, PROTEIN INSTABILITY AND/OR STABILITY INDUCERS, AND PROTEIN ACTIVITY ASSESSMENT KYOTO UNIVERSITY (JP) 2015-05-14 US disclosed
US-20150133467-A1 SCREENING METHOD, PROTEIN INSTABILITY AND/OR STABILITY INDUCERS, AND PROTEIN ACTIVITY ASSESSMENT KYOTO UNIVERSITY (JP) 2015-05-14 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150133467-A1 SCREENING METHOD, PROTEIN INSTABILITY AND/OR STABILITY INDUCERS, AND PROTEIN ACTIVITY ASSESSMENT IGF2BP1, IGF2BP2, IGF2BP3 ALDH1A1 2338/4885TSHR 3338/4885DYRK1A 3483/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.